The eye in epidermolysis bullosa

British Journal of Ophthalmology

Volumn 83, Issue 3, 1999, Pages 323-326

  Tong, L ^a   Hodgkins, P R ^a,b   Denyer, J ^a   Brosnahan, D ^a   Harper, J ^a   Russell Eggitt, I ^a   Taylor, D S I ^a   Atherton, D ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BLISTER; CHILD; ECTROPION; EPIDERMOLYSIS BULLOSA; EYE DISEASE; EYELID DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMBLEPHARON;

EID: 0032992326     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.3.323     Document Type: Article

References (20)

1. Brodie SE. Ophthalmological aspects of epidermolysis bullosa. In: Lin AN, Carter DM, eds. Epidermolysis bullosa. Basic and clinical aspects. New York: Springer-Verlag, 1992:185-90.
2. Lin AN, Murphy F, Brodie SE, et al. Review of ophthalmic findings in 204 patients with EB. Am J Ophthalmol 1994;118:384-90.
3. McKenna KE, Hughes AE, Bingham EA, et al. Linkage of epidermolysis bullosa simplex to keratin gene loci. J Med Genet 1992;29:568-70.
4. McGrath JA, Gatalica B, Christiano AM, et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 1995;11:83-6.
5. Pulkkinen L, Gerecke DR, Christiano AM, et al. Cloning of the beta 3 chain gene (LAMB3) of human laminin 5, a candidate gene in junctional epidermolysis bullosa, Genomics 1995;25:192-8.
6. Gedde-Dahl T Jr, Dupuy BM, Jonassen R, et al. Junctional epidermolysis bullosa inversa (locus EBR2A) assigned to 1 q31 by linkage and association to LAMC1. Hum Mol Genet 1994;3:1387-91.
7. Vailly J, Pulkkinen L, Christiano AM, et al. Identification of a homozygous exon skipping mutation in the LAMC2 gene in a patient with Herlitz's junctional epidermolysis bullosa. J Invest Dermatol 1995;104:434-7.
8. Uitto J, Christiano AM. Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 1994;287:16-22.
9. Christiano AM, Uitto J. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp Dermatol 1996;5: 1-11.
10. McDonnell PJ. The ocular signs and complications of EB. J Roy Soc Med 1988;81:576-8.
11. Destro M, Wallow IHL, Brightbill FS. Recessive dystrophic epidermolysis bullosa. Arch Ophthalmol 1987;105:1248.
12. Sharkey JA, Kervick GN, Jackson AJ, et al. Cornea plana and sclerocornea in association with recessive epidermolysis bullosa dystrophica. Cornea 1992;11:83-5.
13. Hachisuka H, Morita M, Karashima T, et al. Keratin 14 gene point mutation in the Kobner and Dowling-Meara types of epidermolysis bullosa simplex as detected by the PASA method. Arch Dermatol Res 1995;287:142-5.
14. Irvine AD, Corden LD, Swensson O, et al. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet 1997;16:184-7.
15. Hovnanian A, de-Prost Y. [Hereditary epidermolysis bullosa: towards classification and genetic counseling based upon identification of molecular defects (published erratum appears in Arch Pediatr 1995;2:292)]. Arch Pediatr 1994;1:1028-33.
16. Phillips RJ, Aplin JD, Lake BD. Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. Histopathology 1994;24:571-6.
17. Vidal F, Aberdam D, Miquel C, et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 1995;10:229-34.
18. Fourel E, Claudy AL. Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa. Ann Dermatol Venereol 1992;119:563-5.
19. Slater SD, McGrath JA, Hobbs C, et al. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa. Histopathology 1992;20:237-41.
20. Simons K, Stein L, Sener EK, et al. Full time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997;104:2143-55.